Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-13, Stock:PFE, The news for the past five days is as follows:
2019-08-06: NEWS1: Here's What's Pushing Teva Pharmaceutical Industries Stock Even Lower Today.NEWS2: Here's What's Pushing Teva Pharmaceutical Industries Stock Even Lower Today.NEWS3: Health Care Sector Update for 08/06/2019: BDX, BHC, MNK, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Health Care Sector Update for 08/06/2019: BDX, BHC, MNK, JNJ, PFE, ABT, MRK, AMGN.NEWS5: SNY vs. PFE: Which Stock Is the Better Value Option?.NEWS6: 3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink.NEWS7: Fear Around Bristol-Myers Squibb Stock is Starting to Fade.
2019-08-07: NEWS1: Pfizer (PFE) Shares Cross 4% Yield Mark.NEWS2: Pfizer (PFE) Shares Cross 4% Yield Mark.NEWS3: Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies.NEWS4: Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies.NEWS5: VLUE, CVX, GM, PFE: ETF Outflow Alert.NEWS6: VLUE, CVX, GM, PFE: ETF Outflow Alert.NEWS7: Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies.NEWS8: Health Care Sector Update for 08/07/2019: CBM, RYTM, GH, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 08/07/2019: CBM, RYTM, GH, JNJ, PFE, ABT, MRK, AMGN.
2019-08-08: NEWS1: Sarepta stock tumbles after Duchenne gene therapy complication.NEWS2: Pfizer Stock Is The Biggest Pharma — But Should You Buy It?.NEWS3: Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approval.NEWS4: Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approval.NEWS5: UPDATE 1-Patient in Sarepta gene therapy trial develops serious illness; shares plunge.NEWS6: Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance.NEWS7: Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance.NEWS8: Sarepta Stock Is Falling Because Its Lead on Pfizer May Be Shrinking.NEWS9: Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approval.NEWS10: Health Care Sector Update for 08/08/2019: CVRS, CAH, PRGO, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Health Care Sector Update for 08/08/2019: CVRS, CAH, PRGO, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance.NEWS13: What You'll Want to Know About Sangamo Therapeutics' Q2 Results.NEWS14: What You'll Want to Know About Sangamo Therapeutics' Q2 Results.NEWS15: ICU Medical, Inc. (ICUI) Q2 2019 Earnings Call Transcript.
2019-08-09: NEWS1: After Hours Most Active for Aug 9, 2019 :  VEON, UXIN, PFE, FIS, VRAY, AVP, CMCSA, EXC, RF, QQQ, PVTL, AKRX.NEWS2: After Hours Most Active for Aug 9, 2019 :  VEON, UXIN, PFE, FIS, VRAY, AVP, CMCSA, EXC, RF, QQQ, PVTL, AKRX.NEWS3: Why Sarepta Therapeutics Stock Tanked on Thursday.NEWS4: Why Sarepta Therapeutics Stock Tanked on Thursday.NEWS5: Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients.NEWS6: Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients.NEWS7: How to Outsmart the Machines for REIT Yields up to 11.1%.NEWS8: How to Outsmart the Machines for REIT Yields up to 11.1%.NEWS9: Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients.NEWS10: Health Care Sector Update for 08/09/2019: VRAY, NKTR, AMRN, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 08/09/2019: VRAY, NKTR, AMRN, JNJ, PFE, ABT, MRK, AMGN.
2019-08-12: NEWS1: US Indexes Close Lower Monday With Concerns Over China.NEWS2: Dow Jones Today: Doth Thou Protest.NEWS3: Stocks - Dow Sinks as Trade Jitters, Growth Worries Slam Markets Again.NEWS4: Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers.NEWS5: Health Care Sector Update for 08/12/2019: NVAX, SXTC, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Health Care Sector Update for 08/12/2019: NVAX, SXTC, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Amgen Wins Enbrel U.S. Patent Litigation Against Novartis.NEWS8: Pfizer Falls 3%.NEWS9: Merger Talk Boosts Pfizer.NEWS10: 5 Big Pharma Showdowns to Watch.NEWS11: Biopharma Tie-Ups and Quebecois Weed Woes.NEWS12: Biopharma Tie-Ups and Quebecois Weed Woes.NEWS13: Biopharma Tie-Ups and Quebecois Weed Woes.NEWS14: 52-Week Company Lows.

Answer: Decrease